Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Uranium has been back in the news lately, not only due to its relationship with geopolitical maneuvering concerning nuclear weapons, but also as a necessary commodity in the global quest for clean, renewable energy.
The United States is the world’s largest producer of nuclear power, accounting for more than 30% of worldwide nuclear generation of electricity. While....More>>>
Source: ThinkstockDecember 19, 2017: The S&P 500 closed down 0.3% at 2,681.48. The DJIA closed down 0.15% at 24,754.26. Separately, the Nasdaq was down 0.4% at 6,963.85.
Tuesday started out as a great day for the markets, but quickly turned for the worse right out of the gate. While Monday showed a lot of promise for the major exchanges, Tuesday was a small step back. Crude oil was up....More>>>
Trumps New Labor Pick Acosta Likely to Be More Nuanced Than Puzder
How Behavioral Economics Can Help You Retire Rich
Securities and Exchange Commission Investor Advocate Rick Fleming said Friday that his office is launching the Policy Oriented Stakeholder and Investor Testing for Innovative and Effective Regulation (POSITIER) initiative,....More>>>
One of the richest men in China has made a big bet on an icon of Europe’s automotive industry.
Li Shufu, the billionaire chairman of Chinese car maker Geely (GELYF), invested about $9 billion buying a stake of almost 10% in Daimler (DDAIF), making him the biggest single shareholder in the owner of Mercedes Benz.
Li, who’s estimated to be worth around $18 billion, has....More>>>
Galectic (NASDAQ:GALT) was our focus ticker in one of the articles in the NASH series we did in February. There, we discussed what makes Galectin stand out among the NASH companies. First, it is not a one-trick pony and has a diverse pipeline outside NASH. Second, unlike Genfit and Intercept, it targets a more difficult area of NASH, namely cirrhosis and fibrosis, and....More>>>
The S&P 500 is stuck in its narrowest range in nearly half a century and trading volume is plumbing multi-month lows. But by September, investors may be pining for the dog days of summer, with data suggesting that it is historically the worst month for stocks.
Since 1928, the S&P 500 has dropped in September 56% of the time, according to Bank of America Merrill....More>>>
Heart diseasestill claims the lives of around 600,000 Americans every year, and uncontrollable cholesterol plays a big role.EsperionTherapeutics Inc. (NASDAQ:ESPR)became oneof2017’s best-performing biotech stocks because it’s developing a drug that could lower this number.
Unfortunately, Esperion recently revealed some disturbing safety data from one of several ongoing late-stage....More>>>